People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.

The drugs have become popular for their significant weight-loss effects, but their high cost has made them inaccessible for many.

Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal with the Trump administration to drop prices for customers. The Wegovy ...

Novo Nordisk (NVO) announced that Wegovy injection 0.25 mg and 0.5 mg and Ozempic are now available at a limited time price of $199 per month to ...

Novo Nordisk's new discount offer is set to run until the end of March, allowing individuals with a preion to purchase the lowest doses of Ozempic and Wegovy for only $199 per month for the first two ...

The GoodRx for Weight Loss telemedicine subscription is available for an introductory rate of $39 per month through January 2026, with a standard price of $119 beginning on Feb. 1, 2026. Medications ...

The U.S. Centers for Medicare and Medicaid Services (CMS) on Tuesday announced that it has secured lower prices for 15 of its ...

Ozempic (semaglutide) is a powerful and versatile drug, offering dual benefits: controlling blood sugar in type 2 diabetes, and facilitating weight loss as a secondary effect. While its primary ...

Novo Nordisk offers Wegovy and Ozempic at $199/month for new self-pay patients, valid for the first two months until March 31, 2026. The promotion aligns with a national agreement to improve access ...